Revenue
Quarterly revenue figures showing top-line growth.
Latest Revenue: $24.06B (2026Q1); +9.9% YoY; +2.7% CAGR since 2011Q1 (15y).
Chart and table show the latest 24 of 61 quarters.
Revenue
EPS
Free Cash Flow
Gross Margin
FCF Margin
P/E Ratio
Cumulative FCF
Shares Outstanding
Rule of 40
Quarterly Revenue Data
Chart and table show the latest 24 of 61 quarters.
| Period | Value |
|---|---|
| 2020Q2 | $18.34B |
| 2020Q3 | $21.08B |
| 2020Q4 | $22.48B |
| 2021Q1 | $22.32B |
| 2021Q2 | $23.31B |
| 2021Q3 | $23.34B |
| 2021Q4 | $9.77B |
| 2022Q1 | $23.43B |
| 2022Q2 | $24.02B |
| 2022Q3 | $20.00B |
| 2022Q4 | $12.55B |
| 2023Q1 | $20.89B |
| 2023Q2 | $21.52B |
| 2023Q3 | $21.35B |
| 2023Q4 | $21.39B |
| 2024Q1 | $21.38B |
| 2024Q2 | $22.45B |
| 2024Q3 | $22.47B |
| 2024Q4 | $22.52B |
| 2025Q1 | $21.89B |
| 2025Q2 | $23.74B |
| 2025Q3 | $23.99B |
| 2025Q4 | $24.56B |
| 2026Q1 | $24.06B |
Healthcare Comparison
1 / 3
Other JNJ Charts
More quarter-by-quarter fundamentals for Johnson & Johnson
1 / 8